Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare CNSX:BUXNYSEARCA:DXDNYSE:MBICVE:SQD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBUXBiomark Diagnostics$0.00$0.00▼$0.00N/AN/AN/A11,500 shsDXDProShares UltraShort Dow30$26.63+0.0%$27.50$24.23▼$35.79$56.19M-1.74837,468 shs667,612 shsMBIMBIA$4.30+2.0%$4.46$3.22▼$7.46$212.06M1.87433,620 shs229,809 shsSQDSQI DiagnosticsC$0.02C$0.02C$0.01▼C$0.18C$6.11M-0.21172,133 shs65,000 shs10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBUXBiomark Diagnostics0.00%0.00%0.00%0.00%0.00%DXDProShares UltraShort Dow30+0.04%+0.11%-1.22%-4.76%-18.84%MBIMBIA+2.14%+0.35%+0.80%-21.55%-22.89%SQDSQI Diagnostics0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBUXBiomark DiagnosticsN/AN/AN/AN/AN/AN/AN/AN/ADXDProShares UltraShort Dow30N/AN/AN/AN/AN/AN/AN/AN/AMBIMBIA2.2144 of 5 stars3.32.00.00.00.02.50.6SQDSQI DiagnosticsN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBUXBiomark Diagnostics 0.00N/AN/AN/ADXDProShares UltraShort Dow30 0.00N/AN/AN/AMBIMBIA 2.50Moderate Buy$6.2545.52% UpsideSQDSQI Diagnostics 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest DXD, SQD, MBI, and BUX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/29/2025MBIMBIAKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$9.00 ➝ $8.00(Data available from 6/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBUXBiomark DiagnosticsN/AN/AN/AN/AN/AN/ADXDProShares UltraShort Dow30N/AN/AN/AN/AN/AN/AMBIMBIA$42M5.15N/AN/A($40.68) per share-0.11SQDSQI DiagnosticsC$3.04M2.01C$0.00 per share8.50C($0.04) per share-0.38Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBUXBiomark DiagnosticsN/AN/A0.00N/AN/AN/AN/AN/AN/ADXDProShares UltraShort Dow30N/AN/A0.00∞N/AN/AN/AN/AN/AMBIMBIA-$444M-$8.87N/AN/AN/AN/AN/A-7.61%8/5/2025 (Estimated)SQDSQI Diagnostics-C$19.14M-C$0.05N/A∞N/AN/AN/A-74.70%N/ALatest DXD, SQD, MBI, and BUX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025MBIMBIA-$0.07-$0.16-$0.09-$1.28$21.00 million$14.00 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBUXBiomark DiagnosticsN/AN/AN/AN/AN/ADXDProShares UltraShort Dow30$1.575.90%N/AN/AN/AMBIMBIAN/AN/AN/AN/AN/ASQDSQI DiagnosticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBUXBiomark DiagnosticsN/AN/AN/ADXDProShares UltraShort Dow30N/AN/AN/AMBIMBIAN/A1.191.19SQDSQI Diagnostics464.330.120.40Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBUXBiomark DiagnosticsN/ADXDProShares UltraShort Dow30N/AMBIMBIA60.95%SQDSQI Diagnostics25.15%Insider OwnershipCompanyInsider OwnershipBUXBiomark DiagnosticsN/ADXDProShares UltraShort Dow30N/AMBIMBIA12.58%SQDSQI Diagnostics50.20%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBUXBiomark DiagnosticsN/AN/AN/ANot OptionableDXDProShares UltraShort Dow30N/A2.11 millionN/ANot OptionableMBIMBIA8050.37 million44.03 millionOptionableSQDSQI Diagnostics147,000407.17 millionN/ANot OptionableDXD, SQD, MBI, and BUX HeadlinesRecent News About These CompaniesArchival Footage of D-DayNovember 1, 2024 | smithsonianmag.comHow bioinformatics is revolutionizing genetic diagnostics?August 4, 2024 | dqindia.comBVAXF BioVaxys Technology Corp.March 28, 2024 | seekingalpha.comSQI Diagnostics Announces Receipt of Intention to Enforce Security from Pivot Financial and Anticipated Voluntary Bankruptcy FilingJune 16, 2023 | finance.yahoo.comCanadian Investment Regulatory Organization Trading Halt - SQDJune 6, 2023 | finance.yahoo.comThis SQI Diagnostics Insider Increased Their Holding In The Last YearMay 18, 2023 | finance.yahoo.comClosing Bell: Sqi Diagnostics Inc flat on Friday (SQD)May 17, 2023 | theglobeandmail.comClosing Bell: Sqi Diagnostics Inc up on Friday (SQD)April 29, 2023 | theglobeandmail.comClosing Bell: Sqi Diagnostics Inc up on Wednesday (SQD)April 27, 2023 | theglobeandmail.comClosing Bell: Sqi Diagnostics Inc down on Monday (SQD)April 25, 2023 | theglobeandmail.comClosing Bell: Sqi Diagnostics Inc down on Thursday (SQD)April 21, 2023 | theglobeandmail.comClosing Bell: Sqi Diagnostics Inc down on Friday (SQD)April 15, 2023 | theglobeandmail.comClosing Bell: Sqi Diagnostics Inc flat on Wednesday (SQD)April 12, 2023 | theglobeandmail.comClosing Bell: Sqi Diagnostics Inc flat on Tuesday (SQD)April 11, 2023 | theglobeandmail.comSQI DIAGNOSTICS ANNOUNCES ISSUANCE OF PREVIOUSLY ANNOUNCED BONUS WARRANTSMarch 20, 2023 | finance.yahoo.comSQI DIAGNOSTICS EXTENDS MATURITY DATE OF PIVOT CREDIT FACILITY AND DEFERRAL OF CERTAIN INTEREST PAYMENTSFebruary 6, 2023 | ca.finance.yahoo.comThe Independent Director of SQI Diagnostics Inc. (CVE:SQD), Gerald Connor, Just Bought 5.8% More SharesDecember 9, 2022 | finance.yahoo.comSQI DIAGNOSTICS EXTENDS MATURITY DATE OF PIVOT CREDIT FACILITY AND ANNOUNCES DEFERRAL OF CERTAIN INTEREST PAYMENTSOctober 19, 2022 | finance.yahoo.comSQI Diagnostics: Top 10 Undervalued Medical Diagnostics & Research Industry Sector Stocks on TSX Venture Exchange (SQD)September 19, 2022 | theglobeandmail.comSQI Diagnostics reports Q3 resultsAugust 30, 2022 | seekingalpha.comMedia Sentiment Over TimeTop HeadlinesView All Headlines3 High-Paying Dividend Stocks That Still Have Safe PayoutsBy Chris Markoch | May 27, 2025View 3 High-Paying Dividend Stocks That Still Have Safe PayoutsApplied Digital: Now the High-Stakes Race to Build BeginsBy Jeffrey Neal Johnson | June 17, 2025View Applied Digital: Now the High-Stakes Race to Build BeginsAlphabet Enters a Bull Market: Is It Time to Buy?By Ryan Hasson | June 14, 2025View Alphabet Enters a Bull Market: Is It Time to Buy?UnitedHealth Stock Dips: Is This a Value Buy Opportunity?By Jeffrey Neal Johnson | June 13, 2025View UnitedHealth Stock Dips: Is This a Value Buy Opportunity?Intel's Dual Gamble: AI Innovation Now, Foundry Fortunes Later?By Jeffrey Neal Johnson | June 8, 2025View Intel's Dual Gamble: AI Innovation Now, Foundry Fortunes Later?DXD, SQD, MBI, and BUX Company DescriptionsBiomark Diagnostics CNSX:BUXBioMark Diagnostics Inc., an oncology focused company, develops cancer diagnostic solutions to detect, monitor, and assess early treatment. It has a collaborative research agreement with the Icahn School of Medicine for clinical studies related to early lung cancer diagnosis. The company was incorporated in 2014 and is headquartered in Richmond, Canada. BioMark Diagnostics Inc. is a subsidiary of Biomark Technologies Inc.ProShares UltraShort Dow30 NYSEARCA:DXD$26.63 +0.01 (+0.04%) Closing price 06/20/2025 04:10 PM EasternExtended Trading$26.62 -0.01 (-0.02%) As of 06/20/2025 06:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ProShares UltraShort Dow30 (the Fund), formerly UltraShort Dow30 ProShares, seeks daily investment results that correspond to twice (200%) the inverse (opposite) of the daily performance of the Dow Jones Industrial Average (DJIA). The DJIA is a price-weighted index maintained by editors of The Wall Street Journal. The Index includes 30 large-cap, blue-chip United States stocks, excluding utility and transportation companies. Components are selected through a discretionary process with no predetermined criteria except that components should be established United States companies. The DJIA is not limited to traditionally defined industrial stocks, instead, the Index serves as a measure of the entire United States market, covering such diverse industries as financial services, technology, retail, entertainment and consumer goods. The Index is a price return index. The Fund's investment advisor is ProShare Advisors LLC.MBIA NYSE:MBI$4.30 +0.09 (+2.02%) Closing price 06/20/2025 03:59 PM EasternExtended Trading$4.32 +0.02 (+0.47%) As of 06/20/2025 04:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.MBIA Inc. provides financial guarantee insurance services to public finance markets in the United States. It operates United States (U.S.) Public Finance Insurance, and International and Structured Finance Insurance segments. The company issues financial guarantees for municipal bonds, including tax-exempt and taxable indebtedness of the U.S. political subdivisions, as well as utility districts, airports, health care institutions, higher educational facilities, housing authorities, and other similar agencies and obligations issued by private entities. It also insures the non-U.S. public finance and global structured finance, including asset-backed obligations; and sovereign-related and sub-sovereign bonds, and privately issued bonds used for the financing for utilities, toll roads, bridges, public transportation facilities, and other types of infrastructure projects, as well as offers third-party reinsurance services. MBIA Inc. was founded in 1973 and is headquartered in Purchase, New York.SQI Diagnostics CVE:SQDC$0.02 0.00 (0.00%) As of 06/14/2023SQI Diagnostics Inc., a precision medicine company, discovers, develops, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide. The company also offers TOR-dx, a lung test, which enables the surgeon to assess the health of the donor's lung; and a COVID-19 at-home antibody test kit; the RALI-Dx, a COVID-19 severity triage lab test; and RALI-fast, a COVID-19 severity triage POC test. In addition, it offers microarray tests for protein and antibody testing workflow. The company was founded in 1999 and is headquartered in Toronto, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New All-Time Highs Coming for Broadcom? Wall Street Says Yes Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer 3 Reasons AMD Could Be the Hottest Stock of the Summer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Robinhood Director Sells Millions, But HOOD Stock Eyes Gains Coinbase Stock Pops as Senate Passes GENIUS Stablecoin Bill Overheated Market? Analysts Watch These Red Flags Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
